Search
Dalzanemdor
go.drugbank.com/drugs/DB21549InvestigationalDalzanemdor has a monoisotopic molecular weight of 456.32 Da. … Dalzanemdor is under investigation in clinical trial NCT05655520 (A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease).
PF-4191834
go.drugbank.com/drugs/DB11645InvestigationalPF-4191834 has been investigated for the basic science of Asthma.
Fedovapagon
go.drugbank.com/drugs/DB11734InvestigationalFedovapagon has been used in trials studying the treatment of Nocturia.
Brivanib alaninate
go.drugbank.com/drugs/DB11865InvestigationalBrivanib alaninate has been investigated for the treatment of Colorectal Cancer.
Asiatic acid
go.drugbank.com/drugs/DB14054InvestigationalFrom Centella asiatica and other plants; shows a variety of bioactivities.
Apc001
go.drugbank.com/drugs/DB17819ExperimentalApc001 is an aptamer developed for the treatment of osteogenesis imperfecta.
TBX-1400
go.drugbank.com/drugs/DB18263InvestigationalTBX-1400 consists of human donor hematopoietic stem and progenitor cells.
DMP-777
go.drugbank.com/drugs/DB18488ExperimentalDMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.
APL-030
go.drugbank.com/drugs/DB18735ExperimentalAPL-030 is a orally-active small molecule inhibitor of GCN2.
CA-170
go.drugbank.com/drugs/DB15772InvestigationalCA-170 is a selective, small molecule inhibitor of PD-L1.